The FDA approved the emergency use of Covaxin and Janssen COVID-19 vaccines in the Philippines.
The Food and Drug Administration (FDA) recently approved the emergency use of Covaxin and Janssen COVID-19 vaccines in the Philippines.
This, as the COVID-19 vaccines developed by India’s Bharat Biotech and Johnson & Johnson’s Janssen Pharmaceuticals were the fifth and sixth to be granted emergency use authorization in the country, next to Pfizer-BioNTech, AstraZeneca-Oxford, Sinovac’s CoronaVac, and Gamaleya’s Sputnik V COVID-19 vaccines.
Indian Ambassador to the Philippines Shambhu Kumaran first broke the news about Bharat Biotech’s Covaxin on social media.
In a tweet, Kumaran thanked the Food and Drug Administration (FDA), the Department of Health (DOH), and Foreign Affiars Secretary Teodoro Locsin Jr. for the approval of Bharat Biotech’s EUA application for Covaxin COVID-19 vaccine in the Philippines.
Delighted that #Covaxin has been granted EUA in the #Philippines. Congratulations @BharatBiotech!Thank you @FDAPhilippines. Appreciate support of @teddyboylocsin @DOHgovph and all friends of India in Philippines! Another decisive step in the long battle together against Covid-19!— Shambhu Kumaran (@shambhukumaran) April 19, 2021
In response to Kumaran’s tweet, Locsin thanked India for its interest to apply for an emergency use authorization (EUA) in the Philippines.
“Thank you, Philippines? You have nothing to thank us for. We thank you, we owe you the lives of our loved ones who would otherwise die because of pure idiots,” Locsin said in a tweet.
THANK YOU, PHILIPPINES? YOU HAVE NOTHING TO THANK US FOR. WE THANK YOU, WE OWE YOU THE LIVES OF OUR LOVED ONES WHO WOULD OTHERWISE DIE BECAUSE OF PURE IDIOTS. THANK YOU, INDIA. THANK YOU. https://t.co/UzKCN9RFuv— Teddy Locsin Jr. (@teddyboylocsin) April 19, 2021
Vaccine czar Secretary Carlito Galvez on Monday announced in a briefing chaired by President Rodrigo Duterte that the Food and Drug Administration had issued the emergency use authorization (EUA) for the Janssen COVID-19 vaccine. Galvez then thanked the Food and Drug Administration for the approval of the EUA.
The emergency use approval for Janssen Pharmaceuticals’ COVID-19 vaccine had been among the fastest to be granted by the Food and Drug Administration.
Earlier, the Food and Drug Administration announced last April 5 that it received an EUA application for the single-dose COVID-19 vaccine last March 31.
Its approval in the Philippines came as regulators in the United States paused its use in the country’s COVID-19 vaccine program after 6 women — out of nearly 7 million vaccine recipients — experienced “extremely rare” blood clots within weeks of their vaccine shot.
While the Food and Drug Administration in the United States had yet to make a decision on the said vaccine, infectious disease expert and White House COVID-19 task force member Dr. Anthony Fauci said that regulators were likely to continue use of Janssen’s COVID-19 vaccine, adding that the vaccine shot could be brought back with some restrictions on age and gender.